NasdaqGS - Delayed Quote • USD
IDEXX Laboratories, Inc. (IDXX)
At close: 4:00 PM EDT
After hours: 4:15 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 10 | 10 |
| Avg. Estimate | 2.87 | 2.79 | 11.04 | 12.59 |
| Low Estimate | 2.84 | 2.75 | 10.95 | 12.12 |
| High Estimate | 2.91 | 2.83 | 11.1 | 13.17 |
| Year Ago EPS | 2.67 | 2.53 | 10.06 | 11.04 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 10 | 10 |
| Avg. Estimate | 1B | 990.99M | 3.94B | 4.33B |
| Low Estimate | 1B | 981.78M | 3.92B | 4.24B |
| High Estimate | 1.01B | 998.04M | 3.96B | 4.41B |
| Year Ago Sales | -- | -- | 3.66B | 3.94B |
| Sales Growth (year/est) | -- | -- | 7.60% | 9.90% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 2.47 | 2.37 | 2.12 | 2.67 |
| EPS Actual | 2.67 | 2.53 | 2.32 | 2.81 |
| Difference | 0.2 | 0.16 | 0.2 | 0.14 |
| Surprise % | 8.10% | 6.80% | 9.40% | 5.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 2.87 | 2.79 | 11.04 | 12.59 |
| 7 Days Ago | 2.88 | 2.78 | 11.04 | 12.56 |
| 30 Days Ago | 3 | 2.85 | 11.13 | 12.7 |
| 60 Days Ago | 3 | 2.85 | 11.14 | 12.71 |
| 90 Days Ago | 2.98 | 2.84 | 11.14 | 12.72 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | -- |
| Up Last 30 Days | 1 | 1 | 2 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | 1 | 2 |
Growth Estimates
| CURRENCY IN USD | IDXX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 7.50% | -- | -- | 7.90% |
| Next Qtr. | 10.30% | -- | -- | 12.30% |
| Current Year | 9.70% | -- | -- | 5.70% |
| Next Year | 14.00% | -- | -- | 12.60% |
| Next 5 Years (per annum) | 12.00% | -- | -- | 11.21% |
| Past 5 Years (per annum) | 17.05% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Morgan Stanley: Overweight to Overweight | 5/14/2024 |
| Maintains | Barclays: Overweight to Overweight | 5/2/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 2/6/2024 |
| Maintains | Barclays: Overweight to Overweight | 2/6/2024 |
| Downgrade | Piper Sandler: Overweight to Neutral | 1/30/2024 |
| Maintains | Goldman Sachs: Buy to Buy | 1/17/2024 |
Related Tickers
MTD Mettler-Toledo International Inc.
1,518.29
-0.29%
WAT Waters Corporation
354.02
-0.54%
MEDP Medpace Holdings, Inc.
397.25
+1.00%
TMO Thermo Fisher Scientific Inc.
594.01
-0.22%
DHR Danaher Corporation
267.11
+0.49%
ILMN Illumina, Inc.
108.53
-2.29%
CRL Charles River Laboratories International, Inc.
223.06
+0.65%
A Agilent Technologies, Inc.
154.64
+0.27%
IQV IQVIA Holdings Inc.
230.09
-0.47%
ICLR ICON Public Limited Company
318.72
+1.27%